First malaria vaccine approved for widespread use

The disease malaria causes widespread misery, especially across Africa. A vaccine developed in the UK by pharmaceutical company GSK has become the first to be approved for large-scale use. Justin Webb speaks to Professor Sir Brian Greenwood who has played a key role in the vaccine’s development and Thomas Breuer who is the Chief Global Health Officer at GSK. Credit: Getty Images